Olive Capital (OC) is an early-stage investment firm focused on the tech and synthetic biology sectors. Our portfolio includes diverse companies in these spaces, including Pardes (NASDAQ: PRDS), Akasa, Science, Substack, Ender, Orchid Health, and Rewind. OC builds on the experience of founding partner Olivia Wang, who previously headed up the US office of ZhenFund, managing an AUM of $2 billion an...